Home > Income Statement > CORONA REMEDIES

CORONA REMEDIES
Revenue

    Back to Income Statement
CORONA REMEDIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Sales ₹1,196 Cr₹10,145 Cr₹884 Cr₹884 Cr

What is the latest Revenue of CORONA REMEDIES ?

The latest Revenue ratio of CORONA REMEDIES is ₹1,196 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹1,196 Cr
Mar2025₹10,145 Cr
Mar2024₹884 Cr
Mar2023₹884 Cr

How is Revenue of CORONA REMEDIES Trending?

Years Revenue % Change
Mar2026 ₹1,196 Cr
-88.21
Mar2025 ₹10,145 Cr
1,047.53
Mar2024 ₹884 Cr
0.00
Mar2023 ₹884 Cr -

Compare Revenue of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,887.5 Cr 3.9% 7.2% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,408.0 Cr 1.8% 6.8% 17.8% Stock Analytics
DIVIS LABORATORIES ₹206,906.0 Cr 6.7% 18.5% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,521.0 Cr -3.7% 5.5% 39.8% Stock Analytics
CIPLA ₹119,032.0 Cr 5.7% 0.6% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.1 Cr -2% -15.8% -8.4% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

3.9%

7.2%

NA
SENSEX

1.2%

1.2%

-5.5%


You may also like the below Video Courses